Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Journal of the American Chemical Society
|
April 20, 2026
Hexacoordinate Ti-Anchored Single-Atom Pd Catalyst for High-Efficiency Cyclohexanone Ammoximation with H<sub>2</sub> and O<sub>2</sub>
Chengwei Zhai, Zhuoya Dong, Yue Ma, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
December 13, 2019
Betaine/GABA transporter-1 (BGT-1) deficiency in mouse prevents acute liver failure in vivo and hepatocytes apoptosis in vitro
Zhenze Liu, Qing Li, Ruling Shen, et al.
Molecules (Basel, Switzerland)
|
April 27, 2024
A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel Disease
Yuqing Huang, Yi Ning, Zhiwei Chen, et al.
Cancer Cell International
|
July 27, 2025
Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma
Wenhao Shi, Haotian Tang, Linjiang Tong, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Journal of the American Chemical Society
|
April 20, 2026
Hexacoordinate Ti-Anchored Single-Atom Pd Catalyst for High-Efficiency Cyclohexanone Ammoximation with H<sub>2</sub> and O<sub>2</sub>
Chengwei Zhai, Zhuoya Dong, Yue Ma, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
December 13, 2019
Betaine/GABA transporter-1 (BGT-1) deficiency in mouse prevents acute liver failure in vivo and hepatocytes apoptosis in vitro
Zhenze Liu, Qing Li, Ruling Shen, et al.
Molecules (Basel, Switzerland)
|
April 27, 2024
A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel Disease
Yuqing Huang, Yi Ning, Zhiwei Chen, et al.
Cancer Cell International
|
July 27, 2025
Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma
Wenhao Shi, Haotian Tang, Linjiang Tong, et al.
Page
of 2